Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 20 results.
User Information
Export Records
  1. 1.   Cancer cells escape autophagy inhibition via NRF2-induced macropinocytosis
  2. Su, Hua; Yang, Fei; Fu, Rao; Li,Xin; French, Randall; Mose, Evangeline; Pu, Xiaohong; Trinh, Brittney; Kumar, Avi; Liu, Junlai; Antonucci, Laura; Todoric, Jelena; Liu, Yuan; Hu,Yinling; Diaz-Meco, Maria T.; Moscat, Jorge; Metallo, Christian M.; Lowy, Andrew M.; Sun, Beicheng; Karin, Michael
  3. Cancer Cell. 2021, May 10; 39(5): 678-693.e11.
  1. 2.   Intestinal non-canonical NF kappa B signaling shapes the local and systemic immune response
  2. Ramakrishnan, Sadeesh K.; Zhang, Huabing; Ma, Xiaoya; Jung, Inkyung; Schwartz, Andrew J.; Triner, Daniel; Devenport, Samantha N.; Das, Nupur K.; Xue, Xiang; Zeng, Melody Y.; Hu,Yinling; Mortensen, Richard M.; Greenson, Joel K.; Cascalho, Marilia; Wobus, Christiane E.; Colacino, Justin A.; Nunez, Gabriel; Rui, Liangyou; Shah, Yatrik M.
  3. Nature communications. 2019, Feb 8; 10(1):
  1. 3.   Integrity of IKK/NF-kappa B Shields Thymic Stroma That Suppresses Susceptibility to Autoimmunity, Fungal Infection, and Carcinogenesis
  2. Zhu, Feng; Hu, Yinling
  3. Bioessays. 2018, Apr; 40(4): e1700131.
  1. 4.   IKKa inactivation promotes Kras-initiated lung adenocarcinoma development through disrupting major redox regulatory pathways
  2. Song, Na-Young; Zhu, Feng; Wang, Zining; Willette Brown, Jami; Xi, Sichuan; Sun, David; Su, Ling; Wu, Xiaolin; Ma, Buyong; Nussinov, Ruth; Xia, Xiaojun; Schrump, David S; Johnson, Peter; Karin, Michael; Hu, Yinling
  3. Proceedings of the National Academy of Sciences of the United States of America. 2018, Jan 23; 115(4): E812-E821.
  1. 5.   Autoreactive T Cells and Chronic Fungal Infection Drive Esophageal Carcinogenesis
  2. Zhu, Feng; Willette Brown, Jami; Song, Na-Young; Lomada, Dakshayani; Song, Yongmei; Xue, Liyan; Gray, Zane; Zhao, Zitong; Davis, Sean R; Sun, David; Zhang, Peilin; Wu, Xiaolin; Zhan, Qimin; Richie, Ellen R; Hu, Yinling
  3. Cell Host & Microbe. 2017, Apr 12; 21(4): 478-493.e7.
  1. 6.   IKK alpha represses a network of inflammation and proliferation pathways and elevates c-Myc antagonists and differentiation in a dose-dependent manner in the skin
  2. Liu, B.; Willette-Brown, J.; Liu, S.; Chen, X.; Fischer, S. M.; Hu, Y.
  3. Cell Death and Differentiation. 2011, Dec; 18(12): 1854-1864.
  1. 7.   Dendritic Cells from Humans with Hypomorphic Mutations in IKBKG/NEMO Have Impaired Mitogen-Activated Protein Kinase Activity
  2. Ma, C. A.; Wang, H. Y.; Temmerman, S.; Zhao, Y. G.; Wu, L. M.; Hornung, R. L.; Wara, D.; Jain, A.
  3. Human Mutation. 2011, Mar; 32(3): 318-324.
  1. 8.   Role of IKK alpha in skin squamous cell carcinomas
  2. Park, E. M.; Liu, B. G.; Xia, X. J.; Zhu, F.; Jami, W. B.; Hu, Y. L.
  3. Future Oncology. 2011, Jan; 7(1): 123-134.
  1. 9.   A selective small-molecule nuclear factor-kappa B inhibitor from a high-throughput cell-based assay for "activator protein-1 hits"
  2. Kang, M. I.; Henrich, C. J.; Bokesch, H. R.; Gustafson, K. R.; McMahon, J. B.; Baker, A. R.; Young, M. R.; Colburn, N. H.
  3. Molecular Cancer Therapeutics. 2009 8(3): 571-581.
  1. 10.   A tale of terminal differentiation IKK alpha, the master keratinocyte regulator
  2. Liu, B. G.; Zhu, F.; Xia, X. J.; Park, E.; Hu, Y. L.
  3. Cell Cycle. 2009 8(4): 527-531.
  1. 11.   Impaired Priming and Activation of the Neutrophil NADPH Oxidase in Patients with IRAK4 or NEMO Deficiency
  2. Singh, A.; Zarember, K. A.; Kuhns, D. B.; Gallin, J. I.
  3. Journal of Immunology. 2009 182(10): 6410-6417.
  1. 12.   Inhibition of transcription factor NF-kappa B signaling proteins IKK beta and p65 through specific cysteine residues by epoxyquinone A monomer: Correlation with its anti-cancer cell growth activity
  2. Liang, M. C.; Bardhan, S.; Pace, E. A.; Rosman, D.; Beutler, J. A.; Porco, J. A.; Gilmore, T. D.
  3. Biochemical Pharmacology. 2006, FEB 28; 71(5): 634-645.
  1. 13.   Suppression of p65 phosphorylation coincides with inhibition of I kappa B alpha polyubiquitination and degradation
  2. Hu, J.; Haseebuddin, M.; Young, M.; Colburn, N. H.
  3. Molecular Carcinogenesis. 2005, DEC; 44(4): 274-284.
  1. 14.   TRAF2 plays a key, nonredundant role in LIGHT-lymphotoxin beta receptor signaling
  2. Kim, Y. S.; Nedospasov, S. A.; Liu, Z. G.
  3. Molecular and Cellular Biology. 2005, MAR; 25(6): 2130-2137.
  1. 15.   Histone deacetylase inhibition down-regulates cyclin D1 transcription by inhibiting nuclear factor-kappa B/p65 DNA binding
  2. Hu, J.; Colburn, N. H.
  3. Molecular Cancer Research. 2005, FEB; 3(2): 100-109.
  1. 16.   The death domain kinase RIP has an essential role in DNA damage-induced NF-kappa B activation
  2. Hur, G. M.; Lewis, J.; Yang, Q. F.; Lin, Y.; Nakano, H.; Nedospasov, S.; Liu, Z. G.
  3. Genes & Development. 2003 17(7): 873-882.
  1. 17.   The role of IKK in constitutive activation of NF-kappa B transcription factor in prostate carcinoma cells
  2. Gasparian, A. V.; Yao, Y. J.; Kowalczyk, D.; Lyakh, L. A.; Karseladze, A.; Slaga, T. J.; Budunova, I. V.
  3. Journal of Cell Science. 2002 115(1): 141-151.
  1. 18.   Induction of monocyte chemoattractant protein 1 by Helicobacter pylori involves NF-kappa B
  2. Mori, N.; Ueda, A.; Geleziunas, R.; Wada, A.; Hirayama, T.; Yoshimura, T.; Yamamoto, N.
  3. Infection and Immunity. 2001 69(3): 1280-1286.
  1. 19.   Ternary complex factors and cofactors are essential for human T-cell leukemia virus type 1 tax transactivation of the serum response element
  2. Shuh, M.; Derse, D.
  3. Journal of Virology. 2000 74(23): 11394-11397.
  1. 20.   Human T-cell leukemia virus type I tax activates transcription of the human monocyte chemoattractant protein-1 gene through two nuclear factor-kappa B sites
  2. Mori, N.; Ueda, A.; Ikeda, S.; Yamasaki, Y.; Yamada, Y.; Tomonaga, M.; Morikawa, S.; Geleziunas, R.; Yoshimura, T.; Yamamoto, N.
  3. Cancer Research. 2000 60(17): 4939-4945.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel